Search hospitals > Ohio > Akron
Children's Hospital Medical Center of Akron
Claim this profileAkron, Ohio 44308
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Lymphoma
Conducts research for Brain Tumor
208 reported clinical trials
5 medical researchers
Summary
Children's Hospital Medical Center of Akron is a medical facility located in Akron, Ohio. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Lymphoma, Brain Tumor and other specialties. Children's Hospital Medical Center of Akron is involved with conducting 208 clinical trials across 393 conditions. There are 5 research doctors associated with this hospital, such as Steven J. Kuerbitz, Erin Wright, Megan Sampson, MD, and Ryan Nofziger, MD.Area of expertise
1Leukemia
Global LeaderStage II
Philadelphia chromosome positive
NTRK1 positive
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
Steven J. KuerbitzChildren's Hospital Medical Center of Akron6 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
48 reported clinical trials
97 drugs studied
Erin WrightChildren's Hospital Medical Center of Akron4 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
40 reported clinical trials
93 drugs studied
Megan Sampson, MDAkron Children's Hospital10 years of reported clinical research
Studies Infections
Studies Viral Diseases
3 reported clinical trials
3 drugs studied
Ryan Nofziger, MDChildren's Hospital Medical Center of Akron1 year of reported clinical research
Studies Brain Ischemia
Studies Hypoxic-Ischemic Brain Injury
1 reported clinical trial
1 drug studied
Clinical Trials running at Children's Hospital Medical Center of Akron
Acute Lymphoblastic Leukemia
Rhabdomyosarcoma
Brain Tumor
Osteosarcoma
Germ Cell Tumors
Astrocytoma
Leukemia
Acute Leukemia
Lymphoma
Lymphoblastic Leukemia-Lymphoma
Imatinib + Chemotherapy
for Acute Lymphoblastic Leukemia
This study is evaluating whether a combination of drugs may help treat patients with a specific type of leukemia.
Recruiting2 awards Phase 3
Levocarnitine
for Chemotherapy-Related Liver Protection in Leukemia and Lymphoma
This phase III trial compares the effect of adding levocarnitine to standard chemotherapy vs. standard chemotherapy alone in protecting the liver in patients with leukemia or lymphoma. Asparaginase is part of the standard of care chemotherapy for the treatment of acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LL), and mixed phenotype acute leukemia (MPAL). However, in adolescent and young adults (AYA) ages 15-39 years, liver toxicity from asparaginase is common and often prevents delivery of planned chemotherapy, thereby potentially compromising outcomes. Some groups of people may also be at higher risk for liver damage due to the presence of fat in the liver even before starting chemotherapy. Patients who are of Japanese descent, Native Hawaiian, Hispanic or Latinx may be at greater risk for liver damage from chemotherapy for this reason. Carnitine is a naturally occurring nutrient that is part of a typical diet and is also made by the body. Carnitine is necessary for metabolism and its deficiency or absence is associated with liver and other organ damage. Levocarnitine is a drug used to provide extra carnitine. Laboratory and real-world usage of the dietary supplement levocarnitine suggests its potential to prevent or reduce liver toxicity from asparaginase. The overall goal of this study is to determine whether adding levocarnitine to standard of care chemotherapy will reduce the chance of developing severe liver damage from asparaginase chemotherapy in ALL, LL and/or MPAL patients.
Recruiting2 awards Phase 3
Blinatumomab + Chemotherapy
for Leukemia
This study is evaluating whether a combination of chemotherapy and a monoclonal antibody may be more effective than chemotherapy alone in treating patients with B-lymphoblastic leukemia or B-ly
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Children's Hospital Medical Center of Akron?
Children's Hospital Medical Center of Akron is a medical facility located in Akron, Ohio. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Lymphoma, Brain Tumor and other specialties. Children's Hospital Medical Center of Akron is involved with conducting 208 clinical trials across 393 conditions. There are 5 research doctors associated with this hospital, such as Steven J. Kuerbitz, Erin Wright, Megan Sampson, MD, and Ryan Nofziger, MD.